Omega Healthcare downgraded to Underperform from Neutral at BofA

BofA downgraded Omega Healthcare (OHI) to Underperform from Neutral with a price target of $46, down from $52. The firm is reducing its FY26 AFFO estimate inline with the Street and lowering its AFFO multiple, citing heightened competitive dynamics, regulatory pressures, and asset quality considerations relative to peers, the analyst tells investors.